C07J 1/0062
Substituted in position 17 alfa not substituted in position 17 beta
Official title: {substituted in position 17 alfa not substituted in position 17 beta}
C07J1/0062 (Substituted in position 17 alfa not substituted in position 17 beta) appears on 10 US grants and 12 published applications in this corpus.
Search patents in C07J- Granted patents
- 10
- Published applications
- 12
- Assignees
- 11
- Inventors
- 45
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for fluoroalkylation of enamines29 Aug 2023US 11,739,066 B2Arxada AG
- Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD1027 Jul 2021US 11,072,632 B2Universite Laval
- 8β-hydrocarbyl-substituted estratrienes for use as selective estrogens27 May 2008US 7,378,404 B2Schering Corporation
- 17α-hydroxy-14β-steroids with hormonal effect30 Jan 2007US 7,169,769 B2Akzo Nobel N. V.
- Non-estrogenic estradiol derivative compounds with anti-oxidative activity20 Aug 2002US 6,436,917 B1Jenapharm GmbH & Co. KG
- C-20 steroid compounds, compositions and uses thereof to treat traumatic brain injury (tbi), including concussions26 Jun 2025US 2025/0206774 A1Oragenics, Inc.
- -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-12 Dec 2024US 2024/0409576 A1Oragenics, Inc.
- Method for Fluoroalkylation of Enamines30 Jun 2022US 2022/0204464 A1Arxada AG
- C-20 steroid compounds, compositions and uses thereof to treat traumatic brain injury (tbi), including concussions16 Jun 2016US 2016/0168190 A1Prevacus, Inc.
- INHIBITORS OF 17Beta-HSD1, 17Beta-HSD3 AND 17Beta-HSD1027 Mar 2014US 2014/0088053 A1Universite Laval
Most cited
By later US patents
- 8β-hydrocarbyl-substituted estratrienes for use as selective estrogens52US 7,378,404 B2Schering Corporation · 2008
- Non-estrogenic estradiol derivative compounds with anti-oxidative activity11US 6,436,917 B1Jenapharm GmbH & Co. KG · 2002
- 9.alpha., 11.beta.-substituted and 11.beta.-substituted estranes8US 4,705,783 ASRI International · 1987
- Process for the conversion of hydroxyl groups into the corresponding fluorine compounds6US 5,760,255 ABayer Aktiengesellschaft · 1998
- 17.alpha.-hydroxy-1,3,5(10),15-estratetraenes and process for their production5US 4,016,269 ASchering Corporation · 1977